Xplico
@xplico.com
Xplico is a market leader in life science valuation. Headquartered in Denmark, we have supported 100+ companies since 2005, including top pharma/biotech companies across EU and US. We support licensing partnership, investment or fundraising decisions by providing multi-scenario valuation analysis for all parties involved, based on solid technical and market knowledge, development plans, risks and competitive environment. We suggest potential term sheets, based on benchmarked deal terms and forecasted split of revenues and costs. Xplico’s unrivalled sensitivity analysis helps you to assess how any change in the development plan or market, will impact the value of the project for each party. Our clients are free to choose the level of assistance and support they need for the valuation: •A comprehensive valuation consultancy on your company/project •Tool-only: Provide you with a valuation tool (Xplico Evaluator) to build your own valuation on an advanced but flexible model •Or anything in between, tailored for your purpose Xplico Evaluator Tool Xplico Evaluator is a highly specialized but flexible, easy to use valuation tool, with integrated risk assessment and powerful analysis features for the life science industry. Xplico Evaluator is built on our long experience with real needs of this industry. The tool has been fine-tuned over the years with valuable inputs from our clients and is today used by 100+ biotech and pharma companies on a day to day basis for partnering, project valuation and portfolio management. Xplico CapTable Tool Xplico has recently launched an advanced cap table tool tailored to simplify complex ownership structures of life science industry. Xplico CapTable is a standardized Excel-based tool which is built and tailored to facilitate syncing up, updating and keeping accurate track of multiple ownership and exit scenarios while still easy to use.
Xplico's Company Logos
Xplico's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#BA8240
Tussock
186, 130, 64
32, 49, 49
0, 30, 66, 27
#D9D9D9
Alto
217, 217, 217
0, 0, 85
0, 0, 0, 15
#83410E
Korma
131, 65, 14
26, 81, 28
0, 50, 89, 49
About Xplico
Xplico is a leading brand in the life science industry, offering innovative solutions for project and portfolio valuation. Since its establishment in 2005, Xplico has been dedicated to providing an easy-to-use and standardized tool for valuation, supporting over 100 life science companies in the EU, US, and Asia. With their extensive experience in valuation, forecasting, and project/portfolio management, Xplico's team of consultants can evaluate your projects, company, or provide support during partnering negotiations.
Xplico currently offers three solutions to cater to the diverse needs of the industry. Xplico Evaluator is a flexible valuation tool with integrated risk assessment and powerful analysis features. Xplico CapTable is an excel-based tool designed to accurately track multiple ownership and exit scenarios.
Additionally, Xplico offers consulting services, ensuring personalized expertise in valuation and project/portfolio management. Stay updated with the latest news and events in the Xplico world, featuring industry conferences such as BioPharm America, LSX Nordic Congress, BIO-Europe, and Nordic Life Sciences Days. Choose Xplico for reliable and comprehensive solutions in the life science industry.
Connect with Xplico today to learn more about their offerings and how they can assist you
Company type
Privately Held
Year founded
2005
Company size
2-10 employees
